Wearing Apparel, Fabric, Or Cloth Patents (Class 424/402)
-
Publication number: 20140170196Abstract: The present invention provides disposable cloths that are designed to reduce itching discomfort when wiped across the vulvar tissue. These disposable cloths are wetted with a composition that includes at least one anesthetic, protectant, buffer, and surfactant. The composition is substantially clear and preferably does not bring about a cooling or stinging sensation when applied to the vulvar tissue. Furthermore, the composition has a pH adapted to vulvar use.Type: ApplicationFiled: December 19, 2012Publication date: June 19, 2014Inventors: Bobby Corry, Russ Hovda, Michael L. Caswell
-
Patent number: 8735124Abstract: An isolated polypeptide comprising the amino acid sequence of serum paraoxonase (PON1) having catalytic efficiency of kcat/KM?106-5·107 M?1min?1 for a G-type organophosphate.Type: GrantFiled: March 15, 2012Date of Patent: May 27, 2014Assignee: Yeda Research and Development Co. Ltd.Inventors: Dan S. Tawfik, Rinkoo Devi Gupta, Moshe Goldsmith, Yaacov Ashani
-
Publication number: 20140141050Abstract: The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues. Furthermore, the invention provides wound dressings, pads or implants comprising the novel non-woven fabrics.Type: ApplicationFiled: June 21, 2012Publication date: May 22, 2014Applicants: BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH, CARL FREUDENBERG KGInventors: Frank Plöger, Denis Reibel, Dirk Grafahrend, Daniel Neumüller
-
Patent number: 8715701Abstract: Protein preparations containing biologically active compounds and the application of the protein preparations obtained, particularly as a component of medicinal and cosmetic preparations as protective substances or in the regeneration of cells and tissues of the human organism, and which can comprise a component of culture media for dermal or hepatic tissues, or for stem cells destined for use in the regeneration of cells and tissues in the human organism.Type: GrantFiled: November 20, 2007Date of Patent: May 6, 2014Assignee: Instytut Medycyny Doswiadczalnej I KlinicznejInventors: Andrzej Lipkowski, Anna Grabowska, Katarzyna Kurzepa, Aleksandra Szczucinska
-
Publication number: 20140105951Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.Type: ApplicationFiled: December 20, 2013Publication date: April 17, 2014Applicant: Allergan, Inc.Inventors: Gregory H. Altman, Rebecca Horan, David J. Horan, Jingsong Chen
-
Publication number: 20140105950Abstract: The present invention relates to a haemostatic material comprising a haemostat agent and a bioadhesive agent. Such a haemostatic material is useful, for example, in effectively controlling bleeding with a reduced compression period compared to the guidance of a minimum of three minutes compression using a haemostatic bandage.Type: ApplicationFiled: March 12, 2012Publication date: April 17, 2014Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardv, Guy Eason, Andrew Hoggarth
-
Patent number: 8697140Abstract: A virucidal disinfectant having broad-range activity includes an acidic phosphorus compound and/or salt thereof, an alcohol, and one or more polyalkylene glycols. The disinfectant, which may also kill bacteria and/or fungi, may be used for the hygienic disinfection of animate and inanimate surfaces. The invention also provides a disinfection method and a product containing a disinfectant.Type: GrantFiled: May 28, 2009Date of Patent: April 15, 2014Assignee: B. Braun Medical AGInventors: Andreas Arndt, Olga Willi
-
Patent number: 8691253Abstract: The invention relates to a method of use, of a mixture of chemical compounds for a shark repellent, as well as methods of protection garments in using such material(s). Generally, there are not many shark repellents. This shark repellent contains a mixture of chemical compounds that are highly toxic and trenchant, which will deter the shark from injured or non-injured humans or animals, once the mixture is immersed in water.Type: GrantFiled: May 18, 2009Date of Patent: April 8, 2014Inventor: Rhonda Tracy
-
Publication number: 20140093549Abstract: An adhesion inhibiting surgical barrier. The surgical barrier includes a wound-facing polymeric coating comprising an enteric polymer; and at least one flexible substrate, the at least one flexible substrate having at least one exterior surface, wherein the polymeric coating is applied to the at least one flexible substrate to substantially cover the at least one exterior surface thereof. A method of inhibiting the formation of adhesions in a patient who has undergone a surgical procedure and a method of repairing a gastric or duodenal perforation are also described herein.Type: ApplicationFiled: December 2, 2013Publication date: April 3, 2014Applicant: Ethicon, Inc.Inventors: Robert W. Van Holten, Jagdishchandra C. Patel
-
Publication number: 20140093548Abstract: The present invention provides a method of decontaminating human skin from noxious substances without a washing and/or massage procedure, wherein the method comprises applying a textile composite to a contaminated skin area for a predetermined period of time, wherein a washing procedure or a massage procedure is not utilized; and removing the textile composite from the contaminated skin area.Type: ApplicationFiled: November 8, 2013Publication date: April 3, 2014Applicant: SNS Nano Fiber Technology, LLCInventors: Jurgen Lademann, Laura M. Frazier, Woraphon Kataphinan
-
Patent number: 8685426Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.Type: GrantFiled: April 26, 2012Date of Patent: April 1, 2014Assignee: Allergan, Inc.Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
-
Publication number: 20140086967Abstract: The present invention provides an adhesive composition for soft tissues, an adhesive composition for wound dressing or a wound dressing composition, not only having low toxicity, low harmfulness and high adhesive strength but also being excellent in workability during application and being capable of forming films of excellent properties. The compound of the present invention is comprised a monomer (A), polymer particles (B) having a specific weight-average molecular weight and a specific volume mean particle diameter, and a polymerization initiator composition (C) containing an organoboron compound is produced.Type: ApplicationFiled: May 9, 2012Publication date: March 27, 2014Applicant: MITSUI CHEMICALS, INC.Inventors: Noriaki Asada, Hiroshi Naruse
-
Patent number: 8674167Abstract: An absorbent article comprising a malodor control composition having at least one volatile aldehyde and an acid catalyst, and methods of use thereof, are provided. The malodor control composition is suitable for a variety of absorbent articles, including use in diapers, toddler training pants, adult incontinence garments, sanitary napkins, pantiliners, interlabial devices, hemorrhoid pads, and the like.Type: GrantFiled: December 16, 2010Date of Patent: March 18, 2014Assignee: The Procter and Gamble CompanyInventors: Ricky Ah-Man Woo, Steven Anthony Horenziak, Rhonda Jean Jackson, Zaiyou Liu, Michael-Vincent Nario Malanyaon, Jason John Olchovy, Christine Marie Readnour
-
Patent number: 8652452Abstract: The present invention relates to the field of perfumery. More particularly, it concerns the use as perfuming ingredients of a 2,4-dialkyl-pyridine of formula (I): in the form of any one of its stereoisomers or a mixture thereof, wherein R1 represents a C1-3 alkyl group; R2 represents a C4-9 linear alkyl group; and the compound has between 10 and 15 carbon atoms. These compounds are useful for imparting odors of the green and/or pyrazine type. The present invention concerns the use of such compounds in the perfumery industry as well as the compositions or articles containing them.Type: GrantFiled: March 10, 2011Date of Patent: February 18, 2014Assignee: Firmenich SAInventors: Estelle Delort, Kirk F. Eidman
-
Publication number: 20140023690Abstract: Surfaces and members having one or more surfaces derived from compositions containing polymers and one or more heat labile and/or incompatible components adsorbed on carrier materials are provided. The heat labile components include materials that, unless adsorbed on a carrier, are transformed at the polymer's processing temperatures (such as for example, heat labile biocides). Incompatible components are materials that generally react or form gels, slimes or precipitates upon mixing. The carrier materials typically include inorganic and/or organic porous materials capable of remaining solid during processing temperatures. Methods for preparing the polymer surfaces and members having polymer surfaces are provided. Members include, but are not limited to, structures, articles, containers, devices, woven/nonwoven articles, remediation materials, and the like.Type: ApplicationFiled: December 21, 2012Publication date: January 23, 2014Inventors: Frank M. Fosco, JR., Edward E. Sowers
-
Patent number: 8632792Abstract: A cooling sensation agent composition with a prolonged cool sensation effect is provided comprising at least one compound selected from the group consisting of aceia or ketal derivatives of 3-(1-menthoxy)propan-1,2-diol represented by Formula (1), single or mixed carbonic esters ol one or two kinds ol alcohols represented by Formula (2), and carboxylic esters represented by Formula (4). A sensory stimulation agoni composition, a flavor or fragrance composition, a beverage or food product, a perfume or cosmetic product, a toiletry product, a daily utensil product or grocery, a fiber, a fiber product, a cloth or a medicine comprising the cooling sensation agent composition; a production method thereof; a cooling processing method of a fiber, fiber product or a cloth, comprising compounding the cooling sensation agent; and new compounds are also provided.Type: GrantFiled: April 1, 2009Date of Patent: January 21, 2014Assignee: Takasago International CorporationInventors: Kenya Ishida, Takashi Aida, Tetsuya Yamamoto
-
Patent number: 8632793Abstract: A treated substrate with improved availability of a beneficial component for transfer to a target surface and methods for making the same are described. The substrate has a contacting surface with a beneficial component that is transferred from the contacting surface to a target surface during use of the article. The beneficial component is applied to the article in such a way as to “Top-Bias” the component on or near the contacting surface of the article.Type: GrantFiled: January 17, 2007Date of Patent: January 21, 2014Assignee: The Procter & Gamble CompanyInventors: Olaf Isele, Joseph Anthony Gatto, Thomas James Klofta, Matthew Gerald McNally, Julie Charlene Rule, James Anthony Staudigel, Kirsten Kae Stone, Sherman Lee Taylor, II
-
Publication number: 20140004166Abstract: An emulsion suitable for incorporation into wet wipes used to clean urine and fecal matter from the skin. The emulsion includes silicone oil and clay. Phase separation is prevented with an emulsification system that includes a gum blend and either a Gemini surfactant restrained to the oil phase or a glucoside-based emulsifier. The gum blend includes at least one gum and propylene glycol alginate.Type: ApplicationFiled: June 24, 2013Publication date: January 2, 2014Inventors: Corey Thomas Cunningham, Jeffery Richard Seidling, Lisa Marie Kroll, Stacy Averic Mundschau
-
Publication number: 20140005616Abstract: Single layer and multi-layer anti-microbial wound care fabrics, gloves, sleeves, anklets, socks, finger cots, masks, and similar wound care articles are disclosed.Type: ApplicationFiled: June 27, 2013Publication date: January 2, 2014Applicant: Ansell LimitedInventors: JEFFREY MORELAND, ROGER EUGENE HUCKFELDT, DION ROSS, ERIC THOMPSON, JAMIE ASHWORTH, MICHAEL ZEDALIS, ANTHONY B. LOPEZ
-
Publication number: 20130337027Abstract: Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an impregnating liquid and a plurality of micro-scale and/or nano-scale solid features spaced sufficiently close to stably contain the impregnating liquid therebetween. The impregnating liquid fills spaces between said solid features, the surface stably contains the impregnating liquid between the solid features, and the impregnating liquid is substantially held in place between the plurality of solid features regardless of orientation of the surface.Type: ApplicationFiled: May 24, 2013Publication date: December 19, 2013Applicant: Massachusetts Institute of TechnologyInventors: J. David Smith, Rajeev Dhiman, Adam T. Paxson, Christopher J. Love, Brian R. Solomon, Kripa K. Varanasi
-
Patent number: 8603549Abstract: According to the invention, a method for inhibiting the formation of stretch marks is disclosed. The method may include applying an oil to a portion of a person's body. The method may also include placing a non-absorbent film over the oil on the portion of the person's body. The method may further include securing the non-absorbent film to the person's body.Type: GrantFiled: May 25, 2012Date of Patent: December 10, 2013Inventor: Svetlana Baker
-
Patent number: 8603054Abstract: A delivery product is used to deliver a skin composition to the skin of a user. The delivery product includes a thermo-responsive polymer film. The polymer film is solid at room temperature but, once contacted with the skin, increases in temperature and degrades. A skin composition is associated with the polymer film. The skin composition can be applied to a surface of the film or can be incorporated into the film. The skin composition is released by the polymer film for treating the skin of the user.Type: GrantFiled: January 30, 2012Date of Patent: December 10, 2013Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Sarah Anne Lemke, Kroy Donald Johnson
-
Publication number: 20130315970Abstract: According to the invention, a method for inhibiting the formation of stretch marks is disclosed. The method may include applying an oil to a portion of a person's body. The method may also include placing a non-absorbent film over the oil on the portion of the person's body. The method may further include securing the non-absorbent film to the person's body.Type: ApplicationFiled: May 25, 2012Publication date: November 28, 2013Inventor: Svetlana Baker
-
Publication number: 20130309286Abstract: The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above 37° C., as well as to the uses of this composition in therapy, in particular in wound healing.Type: ApplicationFiled: November 29, 2011Publication date: November 21, 2013Applicant: BIOTEC PHARMACON ASAInventors: Rolf Engstad, Dag-Eirik Ramsoy, Erik Steene
-
Publication number: 20130295151Abstract: The present invention relates to a process for the treatment of a cellulosic molded body, wherein the molded body is contacted with an acid solution of a chitosan. The process according to the invention is characterized in that the chitosan has a deacetylation degree of at least 80%, a nitrogen content of at least 7 w %, preferably at least 7.5 w %, a weight average molecular weight Mw (D) of 10 kDa to 1000 kDa, preferably 10 kDa to 160 kDa, and a viscosity in 1 w % solution in 1 w % acetic acid at 25° C. of 1000 mPas or less, preferably 400 mPas or less, in particular preferably 200 mPas or less.Type: ApplicationFiled: August 27, 2009Publication date: November 7, 2013Applicant: Lenzing AktiengesellschaftInventors: Sigrid Redlinger, Werner Richardt, Heinrich Firgo
-
Publication number: 20130295150Abstract: The invention features a galvanic particulate including a first conductive material and a second conductive material, wherein both the first conductive material and the second conductive material are exposed on the surface of the particulate, wherein the particle size of the particulate is from about 10 nanometers to about 100 micrometers, wherein the second conductive material comprises from about 0.01 percent to about 10 percent, by weight, of the total weight of the particulate, and wherein the difference of the standard potentials of the first conductive material and the second conductive material is at least about 0.2 V.Type: ApplicationFiled: April 25, 2013Publication date: November 7, 2013Applicant: Johnson & Johnson Consumer Companies, Inc.Inventor: Johnson & Johnson Consumer Companies, Inc.
-
Publication number: 20130287829Abstract: The present invention utilizes the pre-sporulation (preconidial) mycelial stage of entomopathogenic fungi and extracts of the preconidial mycelium as insect and arthropod attractants and/or pathogens. The preconidial preparations can be employed to limit the zoonotic and plant diseases they transmit. The fungus can be cultivated on grain, wood, agricultural wastes or other cellulosic material and extracts can be made thereof. More than one fungus and substrate can be used in combination with one or more antimicrobial, antiprotozoal, antiviral, or genetically modified agents that result in reduced spread of contagions and lessens the damage they inflict on animals and plants.Type: ApplicationFiled: June 20, 2013Publication date: October 31, 2013Inventor: Paul Edward Stamets
-
Publication number: 20130280311Abstract: This application features methods of treating (e.g., reducing, ameliorating, or preventing) skin damage (e.g., induced by UVB) by decreasing the level or activity of VEGF-A, e.g., in the skin, of a subject.Type: ApplicationFiled: January 11, 2013Publication date: October 24, 2013Inventors: Michael Detmar, Kentaro Kajiya
-
Patent number: 8557269Abstract: A paper tissue and products made from paper tissue, such as paper handkerchiefs, facial tissues, bath and cosmetic tissues, paper tissue wipes of any kinds and the like. The invention describes both the process for making a smooth and absorbent lotioned paper tissue, with high transferability of the lotion. The process steps comprises the steps of (a) providing a paper tissue web continuously moving next to a lotion application unit comprising at least one rotating surface, (b) transferring said lotion onto one rotating surface,’(c) expulsing said lotion from the said rotating surface into a stream of lotion droplets, by primarily the centrifugal force of the rotation of said rotating surface, (d) intercepting said paper tissue with said stream of lotion droplets. The invention also describes a paper tissue comprising a lotion distributed as discrete deposits on its surface. The deposits have a high local concentration of lotion and cover a relatively small area of the tissue.Type: GrantFiled: April 14, 2005Date of Patent: October 15, 2013Assignee: The Procter & Gamble CompanyInventors: Joerg Kleinwaechter, Dirk Butz, Curtis Allen Marcott, Luigi Di Girolamo
-
Patent number: 8545861Abstract: A fibrous web, in particular tissue web treated with a lotion composition based on an O/W emulsion comprising: (A) at least one oil; (B) an (O/W) emulsifier or (O/W) emulsifier combination; and (C) 6 to 30 weight % of water; wherein the weight % values relate to the total weight of the lotion composition. Since in the above lotion composition the external phase is aqueous, a web treated therewith can easily be wet by water and does not float on the water if it is to be disposed in a toilet.Type: GrantFiled: December 22, 2004Date of Patent: October 1, 2013Assignee: SCA Hygiene Products GmbHInventors: Guido Baumöller, Rolf Kawa, Stephan Eichhorn, Roland Sporer
-
Patent number: 8541439Abstract: The instant invention describes an anti-biofouling structure for placement onto structures or surfaces that are exposed to aquatic environments. Embedded within the anti-biofouling structure are agents that can diffuse out of the structure and prevent the formation and/or accumulation of plant and animal species build-up that creates biofouling. The instant invention also describes a system for preventing biofouling of an object stored in an aquatic environment which includes the anti-biofouling structure, and a protective cover element constructed and arranged to fit various structures, such as boat propellers.Type: GrantFiled: July 6, 2011Date of Patent: September 24, 2013Assignee: Biofouling Sloutions, Inc.Inventors: Fletcher Eyster, Fred Zucker
-
Publication number: 20130236521Abstract: The present disclosure is directed to method of treating a herpes virus. In one embodiment, the method includes adding an effective amount of stannous fluoride (SnF2) to a dosage form. The dosage form may be a scrim, a liquid (e.g., a nasal mist, an aerosol spray, a liquid eye drop, a liquid bandage, and the like), a mucoadhesive or a lip balm.Type: ApplicationFiled: March 7, 2013Publication date: September 12, 2013Applicant: HERPX LLCInventors: Thomas Blake, Thomas S. Parigian, David E. Walsh
-
Patent number: 8524255Abstract: A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the delay and decomposition of the agents in passing through the intestinal tract. The delivery system comprises a supportive substrate with bilateral lingual vestibular flanges connected at the anterior midline to form a ‘U’ like shape for fitting in the potential space of the bilateral lingual vestibules, and further comprising a handle or tab for holding the device in the mouth of a patient with altered consciousness to prevent aspiration or premature swallowing. The pharmaceutical dosage-form is formulated and shaped to contact the mucosal tissues and may include mucoadhesive compounds, retentive compounds, and/or additional payload enhancers, such as permeation enhancers and flavor enhancers.Type: GrantFiled: October 3, 2011Date of Patent: September 3, 2013Assignee: noesisBIO LLCInventor: Garrett Douglas Blundell
-
Publication number: 20130224273Abstract: Topical sanitizer includes avenanthramides, which is an active component of oats that is beneficial to the skin. The topical sanitizer is used preferably in conjunction with gloves that have an inner coating that includes avenanthramides. By using topical sanitizer that includes avenanthramides before and after wearing gloves, the skin of the person wearing the glove is more exposed to the beneficial avenanthramides all during the workday, not just when wearing gloves. The result is healthier, much softer and more comfortable skin on the hands.Type: ApplicationFiled: April 16, 2013Publication date: August 29, 2013Applicant: THE IDEA FOLDER LLCInventors: Mark James Redmond, Joseph H. Neuser
-
Publication number: 20130224272Abstract: Compositions containing about 0.6% to about 20% of tea tree oil are described. Some compositions are in the form of solutions, suspensions, spray, lotions, gels, pastes, medicated sticks, balms, cleansers (including shampoos and soaps), creams, or ointments. Also described are compositions and methods for use in treating ocular Demodex infestations and related conditions using such compositions.Type: ApplicationFiled: April 8, 2013Publication date: August 29, 2013Applicant: TissueTech, Inc.Inventor: TissueTech, Inc.
-
Publication number: 20130216596Abstract: Delivery system based on polymeric nanocapsules which contain microemulsions, and their use in the preparation of pharmaceutical, cosmetic and/or alimentary compositions.Type: ApplicationFiled: March 21, 2013Publication date: August 22, 2013Applicant: LIPOTEC, S.A.Inventor: LIPOTEC, S.A.
-
Publication number: 20130202668Abstract: A cooling composition impregnated on a personal towelette which provides a cooling sensation to the body when wiped across the skin. The application of the towelette containing the cooling composition reduces the symptoms of heat due to hot flashes due to menopause, physical exertion, or high temperatures. The composition provides effective cooling but is mild to the skin since it contains active ingredients in combination with skin soothing compounds. The cooling composition of the present invention is made of a combination of natural herbs and botanicals specifically selected to provide synergistic cooling effects.Type: ApplicationFiled: August 1, 2012Publication date: August 8, 2013Inventors: Deborah Bolner Prost, Linda K. Caldwell
-
Publication number: 20130202669Abstract: Provided are method of generating a fiber from a globular protein such as albumin. Also provided are albumin fibers and fabrics and methods of using same for bonding a damaged tissue or for ex vivo or in vivo formation of a tissue.Type: ApplicationFiled: March 28, 2013Publication date: August 8, 2013Applicant: Technion Research & Development Foundation LimitedInventor: Technion Research & Development Foundation Limited
-
Publication number: 20130195945Abstract: Barrier treatment compositions using conidia of entomopathogenic fungi and methods for applying and using the same for bed bug population control and prevention are disclosed. The compositions and methods of the invention provide residual biopesticides control for bed bug populations using barrier treatment compositions transferring conidia of entomopathogenic fungi to a population of bed bugs providing effective kill within about 24 hours to about 10 days. The compositions and methods provide significantly enhanced horizontal transmission of the conidia of the entomopathogenic fungi providing enhanced bed bug control without detrimental effects of bed bug tolerance, resistance and/or negative impact on humans or animals contacting the residual biopesticides.Type: ApplicationFiled: January 31, 2013Publication date: August 1, 2013Applicant: THE PENN STATE RESEARCH FOUNDATIONInventor: THE PENN STATE RESEARCH FOUNDATION
-
Publication number: 20130189338Abstract: Demineralized bone matrix fibers and demineralized bone compositions are provided. Implantable demineralized bone matrix compositions include elongated bone fibers having an average length from about 2 cm to about 6 cm and an aspect ratio from about 50:1 to about 1000:1. The demineralized bone matrix compositions also include a carrier in an amount sufficient to produce a cohesive formable mass. The elongated fibers can easily entangle to provide an improved demineralized bone matrix having increased osteoconductivity.Type: ApplicationFiled: January 19, 2012Publication date: July 25, 2013Applicant: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, Guobao Wei
-
Patent number: 8491926Abstract: A system and method are provided for targeted and individualized delivery of multiple skin benefit agents to the skin of a user. The image of a predetermined treatment area of the user's skin is first captured by an imaging device. Selective data input from analysis tools and the end user is then analyzed by a computing device to generate a unique skin profile for the user, which is indicative of the skin conditions at the predetermined treatment area. Based on such skin profile, a printing device prints out one or more cosmetic delivery sheets that can be applied to the predetermined treatment area. Each of the cosmetic delivery sheets contains a substrate with multiple isolate, discrete regions, while at least two of the regions are imprinted with different skin benefit agents for treating different skin conditions of the predetermined treatment area according to the unique skin profile of the user.Type: GrantFiled: December 8, 2010Date of Patent: July 23, 2013Assignee: ELC Management LLCInventors: Fatemeh Mohammadi, Tsung-wei Robert Mou, Lisa Ou
-
Patent number: 8480852Abstract: Wiping products, such as facial tissues, contain an interior temperature change composition and an exterior hydrophilic lotion composition that can provide a cooling sensation when contacted with the skin of a user. The temperature change composition, for instance, can contain one or more phase change agents that undergo a phase change at slightly elevated temperatures. The phase change agents, in one embodiment, can have a relatively high heat of fusion. When undergoing a phase change, the phase change agents absorb heat and thereby provide a cooling feeling to the skin of a user. The hydrophilic lotion composition may contain a carrier and a thermo-reversible gelling agent. The hydrophilic lotion composition maintains the temperature change composition within the tissue and helps to prevent skin irritation.Type: GrantFiled: November 20, 2009Date of Patent: July 9, 2013Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Scott W. Wenzel, Jeffery Richard Seidling, Helen Kathleen Moen, Frederick John Lang, Stephanie Diana Scharenbroch, Mark Anthony Barnes, Judy Marie Casper
-
Patent number: 8475817Abstract: The present invention relates to substantially dry personal cleansing articles useful for cleansing the skin or hair. These articles are used by the consumer by wetting the substantially dry article with water and then rubbing the article against the skin or hair. The article comprises a water-insoluble substrate having non-fibrous polymeric raised areas on at least one surface of said water insoluble substrate that are formed of a polymeric material having a Shore A hardness of no more than about 80, and a lathering surfactant releasably associated with the substrate. Preferably, the articles of the present invention further comprise a conditioning component.Type: GrantFiled: July 31, 2007Date of Patent: July 2, 2013Assignee: The Procter & Gamble CompanyInventors: Erik John Hasenoehrl, Sabrina Turacchio
-
Publication number: 20130164360Abstract: The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.Type: ApplicationFiled: December 21, 2011Publication date: June 27, 2013Inventors: Yi-Lan Wang, Ying Sun, Guanghui Zhang, Chunlin Yang
-
Patent number: 8470351Abstract: The present invention is directed to providing antimicrobial compositions consisting of a polymeric material and, embedded therein, an antimicrobial compound. The antimicrobial compound contains at least one quaternary ammonium group, at least one hydrocarbon chain comprising a minimum of 10 carbon atoms and a maximum of 24 carbon atoms, and one or more anions to balance the charge of the quaternary ammonium groups. The invention is also directed to a method of making antimicrobial compositions containing an antimicrobial compound embedded in a polymeric material.Type: GrantFiled: May 30, 2008Date of Patent: June 25, 2013Assignees: The Research Foundation of the City University of New York, Pace University, Long Island UniversityInventors: Robert Engel, JaimeLee Iolani Rizzo, Karin Melkonian Fincher, Gary Innocenti
-
Patent number: 8460690Abstract: A process for deterring behavior of pets which includes providing a device comprising a reflective metalized plastic sheet having a thickness of about 0.5 to 10.0 mils, having a reflective and non-reflective side and capable of making a sound when the sheet is flexed by pressure from a pet, a fibrous layer, and a decorative fabric layer, where the layers are joined together to form the device, and the reflective side of said reflective plastic layer is oriented outward, where the device is capable of being folded or rolled-up, and when placed on an object, the device deters pets from getting on said object.Type: GrantFiled: March 17, 2011Date of Patent: June 11, 2013Assignee: PetzOff InternationalInventor: Jeremiah S. Downs
-
Publication number: 20130136781Abstract: The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.Type: ApplicationFiled: January 22, 2013Publication date: May 30, 2013Inventors: Anne Jessica GORMAN, Sanyog Manohar PENDHARKAR
-
Publication number: 20130095160Abstract: Resorbable biomaterials including polystatin polymers and devices including the resorbable biomaterials are described. Methods of making the resorbable biomaterials and devices including resorbable biomaterials are also described.Type: ApplicationFiled: September 12, 2012Publication date: April 18, 2013Inventors: Gautam S. Ghatnekar, Wayne H. Kaesemeyer
-
Publication number: 20130095161Abstract: The present disclosure relates to compositions A composition comprising a polymerization product of an anionic polysaccharide, a diisocyanate, and a linker, wherein the linker comprises i) an ether group, an ester group, or a combination thereof and, ii) a chain extender comprising a hydroxyl group, a thiol group, an amine group, or a combination thereof. The disclosure further relates to medical devices comprising the aforementioned compositions, and to methods of using the compositions and devices. More particularly, the compositions, devices and methods described herein are useful for preventing protein adhesions in vivo, particularly the Vroman effect.Type: ApplicationFiled: October 5, 2012Publication date: April 18, 2013Inventors: Lukas Bluecher, Michael Milbocker
-
Publication number: 20130084320Abstract: The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a disease or injury site. The subsequent migration of cells from these tissues into the lesion or wound, followed by deposition of the appropriate extracellular matrix, results in closure of the lesion or fusion of a tissue gap.Type: ApplicationFiled: November 29, 2012Publication date: April 4, 2013Applicant: DEPUY MITEK, LLCInventor: DePuy Mitek, LLC